Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
4
Neutral
7
Bullish
3
Bearish
35
Neutral
8
Bullish
3
Bearish
31
Neutral
1
Bullish
0
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 24 Cr
P/E
—
Shree Ganesh Biotech India Limited specializes in the production, processing, and marketing of high-quality hybrid seeds for various crops including corn, sunflower, cotton, paddy, and grain sorghum.
Originally established as a commercial and investment entity in 1982, the company underwent a significant transformation in 2010 with the merger of Shree Ganesh Bio-Tech (India) Private Limited, shifting its focus to the biotech sector.
The company has a notable history of corporate evolution, adapting to market needs and strategically realigning its business model toward agriculture biotechnology.
Despite initial ventures in property and finance, the company's swift adaptation to the bio-tech domain illustrates a dynamic strategic approach to capture growth in the agri-tech market.
Pharmaceuticals
Biotechnology
24 Cr
Low Risk
—
74.2
—
0.4
1.15
0.58
Sales CAGR
1Y
13.21%
3Y
-31.89%
5Y
56.15%
10Y
30.31%
Profit CAGR
1Y
-54.84%
3Y
-52.05%
5Y
3.37%
10Y
-7.08%
ROE
TTM
0.26%
3Y
1.56%
5Y
1.88%
10Y
3.33%
ROCE
TTM
0.26%
3Y
2.10%
5Y
2.57%
10Y
3.79%
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
755.65 | 890 Cr | 30.81 | 3.48 | 0.10 | 10.92 | 16.89 | 7.42 | |
125.05 | 251 Cr | 14.83 | 2.89 | 0.00 | 19.49 | 16.44 | 14.40 | |
29.45 | 66 Cr | 16.02 | 0.69 | 0.00 | 4.22 | 7.95 | 2.48 | |
0.61 | 24 Cr | — | 0.38 | 0.00 | 0.26 | 0.26 | 0.25 | |
2.72 | 22 Cr | — | 2.34 | 0.00 | -17.64 | -3.52 | -1.13 | |
20.49 | 15 Cr | — | 1.01 | 0.00 | -23.51 | -15.08 | -7.97 | |
21.75 | 13 Cr | 31.52 | 4.46 | 0.00 | 14.14 | 16.25 | 4.15 |
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
SLUGGISH
Profitability
LOW MARGIN
Technicals
Bearish
Risk
LOW RISK
